Home > Healthcare & Medical Devices > Cerebral Oximetry Monitoring Market

Cerebral Oximetry Monitoring Market - By Application (Cardiac Surgery, Vascular Surgery), By Age Group (Adult, Pediatric), By End-use, & Forecast, 2023 – 2032

  • Report ID: GMI6544
  • Published Date: Aug 2023
  • Report Format: PDF

Cerebral Oximetry Monitoring Industry Analysis

Cerebral Oximetry Monitoring Market size was valued at around USD 205.6 million in 2022 and is projected to reach over USD 410.7 million by 2032. This incremental growth rate is owing to increasing prevalence of neurological ailments coupled with increasing number cardiovascular surgeries globally.
 

Cerebral Oximetry Monitoring Market

To get more details on this report: Request Free Sample PDF
 

Growing awareness regarding patient safety and cerebral desaturation associated with rising demand for non-invasive brain monitoring systems and technological advancements among others is anticipated to drive the market progress. The cerebral oximetry monitoring industry is witnessing significant growth in the recent years owing to factors such as ageing population, technological advancements, enhanced patient safety, among others.
 

Geriatric population are more susceptible to chronic ailments and the number of surgeries and medical interventions involving elderly patients have increased significantly. Cerebral oximetry monitoring plays a crucial role in optimizing patient outcomes in this demographic. Continuous advancements in sensor technology and monitoring devices have led to more accurate and reliable measurements, making cerebral oximetry monitoring a valuable tool for healthcare professionals. Cerebral oximetry monitoring helps healthcare professionals identify early signs of cerebral desaturation, allowing them to take immediate actions to prevent potential neurological complications. Therefore, the cerebral oximetry monitoring industry is witnessing substantial growth and innovation, driven by the demand for better diagnosis and treatment of chronic ailments and technological advancements in cerebral oximetry monitoring devices.
 

Cerebral oximetry monitoring is a medical technology that measures the oxygen saturation levels in the brain. It is a non-invasive method that helps to assess the adequacy of oxygen carried by hemoglobin in the cerebral tissues of the brain.
 

However, high cost associated with advance cerebral oximetry monitoring devices can pose a significant challenge and impede the market growth in the coming years. The cost of these devices can be a significant barrier to adoption, especially for healthcare facilities with budget constraints or in regions with limited resources. For instance, the cost of adult cerebral oximetry monitoring system ranges between USD 2,000 to USD 10,000 and may vary according to the technology and sensors used in these devices. This high cost can limit the widespread adoption of cerebral oximetry monitoring technology in certain areas. The high cost of devices may lead to delayed or limited coverage by healthcare payers, affecting hospitals and clinics' ability to invest in the technology.
 

Moreover, availability of traditional cost-effective monitoring methods can hinder the product adoption rate. The high capital investment required for equipment purchase, installation, maintenance, and regular upgrades can affect the financial viability of healthcare providers. Thus, the aforementioned factors are anticipated to impede the market trends.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact that influenced the cerebral oximetry monitoring market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions impacted the market growth. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of cardiovascular disease and surgical procedures. The COVID-19 pandemic reduced visits to healthcare facilities, causing medical services in several countries to be delayed, including cardiac, vascular and neurology surgeries among others. Cerebral oximetry monitoring is commonly used in high-risk surgeries, and with a reduction in these procedures, the demand for monitoring devices decreased.
 

The global supply chain disruptions caused by lockdowns and travel restrictions affected the production and distribution of medical devices, including cerebral oximetry monitoring devices. This led to delays in manufacturing and delivery, causing shortages and further hindering market growth. During the pandemic, healthcare facilities intensified their infection control measures, which included reducing the use of certain non-essential medical devices to minimize the risk of cross-contamination. These conditions have led to decreased usage of cerebral oximetry monitoring devices in several healthcare settings.
 

Cerebral Oximetry Monitoring Market Trends

Increasing prevalence of neurological disorders is anticipated to drive the market demand. Cerebral oximetry is a non-invasive monitoring technique that measures regional oxygen saturation (rSO2) in the brain. It is commonly used during surgeries, especially cardiac and vascular procedures, to monitor and optimize cerebral oxygen levels. Neurological disorders and conditions such as stroke, traumatic brain injury, and other neurosurgical interventions often necessitate continuous monitoring of cerebral oxygenation levels to minimize the risk of brain damage.
 

For instance, according to the CDC data, in 2021, over 223,135 people in the U.S. were estimated to be hospitalized due to traumatic brain injury and accounting around 69,473 deaths. As these disorders can have severe consequences on brain health, there is a growing demand for cerebral oximetry monitoring  for traumatic brain injury assessment and optimize brain oxygenation during medical interventions and surgeries. The aging population, sedentary lifestyles, and other lifestyle-related factors contribute to the rise in neurological conditions.
 

Cerebral oximetry monitoring is particularly crucial during surgical procedures that involve risks to brain perfusion, such as cardiac surgeries, vascular surgeries, and neurosurgery. Monitoring cerebral oxygen levels during these procedures allows healthcare providers to make real-time adjustments to maintain adequate brain perfusion, reducing the risk of post-operative neurological complications. The increasing number of surgical procedures globally further drives the demand for cerebral oximetry monitoring systems. Ongoing advancements in medical technology have led to the development of more advanced and user-friendly cerebral oximetry monitoring devices. These devices offer improved accuracy, reliability, and ease of use, making them more attractive to healthcare facilities. As technology continues to evolve, newer and more sophisticated devices are likely to be introduced, further stimulating market share.
 

Cerebral Oximetry Monitoring Application Segmentation

Cerebral Oximetry Monitoring Market Size, By Application,

To get more details on this report: Request Free Sample PDF
 

Based on application, the cerebral oximetry monitoring market is segmented as cardiac surgery, vascular surgery, and others. The cardiac surgery segment accounting over 51% revenue share in 2022. Cardiac surgeries, including cardiopulmonary bypass, can increase the risk of oxygen deprivation and ischemia in the brain due to altered blood flow. Cerebral oximetry monitoring provides real-time feedback on cerebral oxygen saturation, allowing healthcare providers to optimize perfusion and ensure adequate oxygen supply to the brain during the procedure. For instance, according to the NCBI data, in 2022, around 400,000 cardiopulmonary bypass surgeries are performed annually in North America and is estimated to increase in the near future. Cerebral oximetry monitoring helps reduce the risk of post-operative neurological complications, such as stroke or cognitive impairment.
 

Cardiovascular diseases, including heart attacks and heart failures, are among the leading causes of morbidity and mortality worldwide. As the prevalence of cardiovascular diseases increases, the number of cardiac surgeries performed also rises, leading to a higher demand for these patient monitoring devices to safeguard brain health during these interventions. Therefore, the rising incidence of cardiovascular diseases, growing awareness and recommendations advancements in technology, focus on patient safety, and favourable reimbursement policy is thereby increasing the demand for cerebral oximetry monitoring in cardiac surgery.
 

Cerebral Oximetry Monitoring Age Group Segmentation

Based on age group, the cerebral oximetry monitoring market is segmented as adult and pediatric. The adult segment exceeded USD 133.4 million in 2022. As the global population ages, there is a higher prevalence of age-related medical conditions, including cardiovascular diseases, neurodegenerative disorders, and other medical conditions that may necessitate surgical interventions. Cerebral oximetry monitoring are essential devices in these cases to ensure optimal brain oxygenation during medical procedures. Neurological disorders, such as stroke, traumatic brain injury, and neurodegenerative diseases, are becoming more common among the adult population.
 

Cerebral oximetry monitoring aids in managing these conditions and guiding treatment decisions. Hospitals and healthcare institutions are placing increased emphasis on perioperative care to optimize patient outcomes specifically among adult population. Cerebral oximetry monitoring plays a vital role in perioperative care for adults by helping healthcare providers identify and address potential cerebral oxygenation issues during and after surgeries.
 

Cerebral Oximetry Monitoring End-use Segmentation

 Cerebral Oximetry Monitoring Market Share, By End-use,

To get more details on this report: Request Free Sample PDF
 

Based on end-use, the cerebral oximetry monitoring market is segmented as hospitals, ambulatory surgical centers and others. The hospitals segment held a dominant business share and accounted for around USD 99 million in 2022. Hospitals offer cerebral oximetry monitoring for a variety of neurological ailments that demonstrate a commitment to patient safety and quality of care. Patients prefer hospitals that utilize advanced monitoring technologies to ensure optimal outcomes, especially for high-risk procedures or surgeries. Hospitals equipped with cerebral oximetry monitoring devices are likely to attract patients that require specialized medical interventions, such as complex surgeries or critical care.
 

Patients seeking advanced treatments are more likely to choose hospitals with the latest monitoring capabilities. Patients with chronic conditions that require continuous monitoring of brain oxygenation prefer hospitals that offer cerebral oximetry monitoring as part of their long-term health management. The ability to provide integrated care within a hospital setting enhances patient outcomes and drives the demand for hospital-based services. Thus, availability and accessibility to advanced diagnosis and treatment incorporating cerebral oximetry monitoring devices coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals.
 

Cerebral Oximetry Monitoring Regional Analysis

North America Cerebral Oximetry Monitoring Market

North America cerebral oximetry monitoring market was valued at USD 85.6 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from neurological disorders, an expanding elderly population, among others. The increasing prevalence of neurological disorders, such as stroke, traumatic brain injury, and epilepsy, emphasizes the need for precise and continuous monitoring of brain oxygenation.
 

Cerebral oximetry devices provide critical data that aids in diagnosis, treatment planning, and ongoing patient management. Healthcare facilities in North America are continuously integrating advance, accurate and user-friendly cerebral oximetry monitoring devices making it easier for healthcare professionals to adopt and utilize the technology.
 

Favorable reimbursement policies in the region for procedures involving cerebral oximetry monitoring, incentivize healthcare facilities to invest in the technology. Various government and non-government organizations are emphasizing on awareness regarding the benefits of cerebral oximetry monitoring through educational programs, medical conferences, and peer-reviewed publications.
 

Cerebral Oximetry Monitoring Industry Leaders

Some of the major players operating in the cerebral oximetry monitoring market are Edwards Lifesciences Corporation, GE Healthcare, Hamamatsu Photonics K.K., ISS, Inc., Masimo Corporation, Medtronic plc, Mespere LifeSciences, Mindray Medical International Ltd., Nihon Kohden Corporation, Nonin Medical, Inc., Sentec AG, Terumo Cardiovascular Systems Corporation among others. These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Cerebral Oximetry Monitoring Industry Leaders:

  • In June 2023, Royal Philips and Masimo corporation collaboratively announced that they had received the U.S. FDA approval for their SedLine, O3 and CO? cerebral oximetry monitoring. This system is integrated with advance monitoring technology that helps clinicians assess and monitor blood saturation in the brain (cerebral oxygenation), anesthetic sedation, and patient respiratory performance with ease. This collaborative strategic approval helped the company to expand their product portfolio and increase the market presence.
     
  • In December 2021, Medtronic plc announced that they had received the U.S. FDA 510(k) clearance for their INVOS 7100 cerebral/somatic oximetry system for children. The INVOS system helps to detect key signals to inform time-critical decisions related to hemodynamic management, ventilation, and resuscitation for premature infants, neonates, children, and other patients treated by pediatric clinicians. This approval helped the company to enhance their R&D capabilities, increase their customer base and enhance their business revenue.
     

Cerebral oximetry monitoring market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report


By Application, 2018 - 2032 (USD Million)

  • Cardiac Surgery
  • Vascular Surgery
  • Others

By Age Group, 2018 - 2032 (USD Million)

  • Adult
  • Pediatric

By End-use, 2018 - 2032 (USD Million)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Rupali Swain, Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Cerebral oximetry monitoring industry value was around USD 205.6 million in 2022 and will reach over USD 410.7 million by 2032.

The cardiac surgery dominated the cerebral oximetry monitoring industry with over 51% share in 2022 as these surgeries, including cardiopulmonary bypass, can increase the risk of oxygen deprivation and ischemia in the brain due to altered blood flow.

North America cerebral oximetry monitoring market size was USD 85.6 million in 2022 and will grow significantly through 2032 owing to the presence of significant industry players, an increase in the number of patients suffering from neurological disorders, an expanding elderly population.

Edwards Lifesciences Corporation, GE Healthcare, Hamamatsu Photonics K.K., ISS, Inc., Masimo Corporation, Medtronic plc, Mespere LifeSciences, Mindray Medical International Ltd., Nihon Kohden Corporation, Nonin Medical, Inc., Sentec AG, Terumo Cardiovascular Systems Corporation among others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 209
  • Countries covered: 18
  • Pages: 145
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount